Clinical Trial Update: A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 clinical trial evaluating guselkumab for moderately to severely active ulcerative colitis, noting that the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Colitis, Ulcerative | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-12-09